CA
RMD icon

Claris Advisors’s ResMed RMD Stock Holding History

Claris Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$732 – 912
2024
Q3 		$732 Buy
+3
New +$670 ﹤0.01% 513

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Claris Advisors's RMD Position: Q4 2024 in Review

Claris Advisors sold out of ResMed (RMD) in Q4 2024, closing a stake of 3 shares — an estimated $732 sold.

Claris Advisors first reported a position in RMD in Q3 2024 and held it in 1 quarter. The position peaked at $732 in Q3 2024. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Claris Advisors reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Claris Advisors sold 3 ResMed shares in Q4 2024, an estimated $732.
  • Claris Advisors first reported a position in ResMed in Q3 2024 and held it in 1 quarter.
  • Claris Advisors's ResMed position peaked at $732 in Q3 2024.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.